Fig. 2From: 4D label-free proteomics analysis of oxygen-induced retinopathy with or without anti-VEGF treatmentComparisons of the heatmaps of the differential proteins expressed in three groups. A Comparisons of the heatmaps of the differential proteins expressed between the ranibizumab group and the OIR group. B Comparisons of the heatmaps of the differential proteins expressed between the OIR group and the normal group. C Comparisons of the heatmaps of the differential proteins expressed between the ranibizumab group and the normal group. Higher red and blue intensities indicate higher degrees of upregulation and downregulation, respectivelyBack to article page